The FRAME Alternatives Laboratory (FAL) has developed an in vitro model to study fatty liver disease associated with chemotherapy.
The global study commissioned by FRAME has revealed that 93.4% of people think more needs to be done to replace and reduce the use of animals in testing and research.
Dr Carol Treasure, the Founder and CEO of specialist animal-free contract testing laboratory XCellR8, has joined FRAME’s Board of Trustees.
FRAME’s international, peer-reviewed scientific journal ATLA (Alternatives to Laboratory Animals), has appointed a new editor-in-chief.
A paper recently published in Regulatory Toxicology and Pharmacology has highlighted opportunities to use one rather than two species for long-term toxicity testing.
#GivingTuesdayNow is a global day of unity in response to Coronavirus. A day where everyone can come together to recognise, celebrate and give thanks for the incredible outpouring of
Since 1979, World Day for Laboratory Animals, has been a catalyst for a global movement to end the use of animals in laboratories around the world and drive their replacement with
This FRAME Summer Studentship Programme has been developed to support undergraduates in undertaking summer research projects in an area relating to the development of alternative
The FRAME Alternatives Laboratory is currently closed but volunteers from the lab are putting their skills to practical use by testing patients for Covid-19.
FRAME has appointed its first Chief Executive Officer, Celean Camp, to drive its overall strategy and operations.